- Spark Newswire

1 minute read

Bullish Arbutus Biopharma Analyst Breaks Down Pipeline Opportunity

Today, 3:24 AM

The expected start of combination clinical trials has H.C. Wainwright bullish on shares of Arbutus Biopharma Corp. (NASDAQ: ABUS). The Arbutus Analyst: Ed Arce raffirmed a Buy rating on shares of Arbutus Biopharma Corp. with a $10 price target.

ABUS

1 minute read

Why This ChemoCentryx Analyst Is Bullish

By Nikhil Dayal

Today, 3:24 AM

H.C. Wainwright analysts remain bullish on ChemoCentryx, Inc. (NASDAQ: CCXI) following an amended new drug application for avacopan. The ChemoCentryx Analyst: Edward White reaffirmed a Buy rating on shares of ChemoCentryx, Inc. with a $28 price target.

CCXI

2 minute read

Why Zeta Global’s Proprietary Customer Database Has BofA Bullish

By Nikhil Dayal

Today, 3:24 AM

A differentiated proprietary customer database has turned a BofA Securities analyst bullish on shares of Zeta Global Corp (NYSE: ZETA). The Zeta Analyst: Koji Ikeda initiated coverage on shares of Zeta Global Corp. with a Buy rating and $12 price target.

ZETA

1 minute read

Why This Hims Analyst Sees Strong Growth Potential In Highly Competitive Market

By Nikhil Dayal

Today, 3:24 AM

The potential for expansion coupled with a highly competitive pharmacy market has a BofA Securities analyst sidelined on shares of Hims & Hers Health, Inc. (NYSE: HIMS).

HIMS

1 minute read

Iterum Therapeutics Analyst Remains Bullish Despite Concerns Over FDA Letter

By Nikhil Dayal

Today, 3:24 AM

A lack of clarity and final decision in the U.S. Food and Drug Administration's (FDA) recent letter to Iterum Therapeutics PLC (NASDAQ: ITRM) failed to deter H.C. Wainwright & Co’s bullish sentiment on Iterum stock.

ITRM

1 minute read

Why A 5-Ship Deal Is Reinforcing This Danaos Analyst’s Bull Case

By Nikhil Dayal

Today, 3:24 AM

A deal involving the acquisition of five ships has furthered a Jefferies analyst's bullish sentiment on Danaos Corp. (NYSE: DAC).

DAC

2 minute read

US Adds 850K Jobs In June: What You Should Know

By Nikhil Dayal

Today, 3:24 AM

U.S. nonfarm payroll growth in June grew by 850,000 jobs, exceeding the Bloomberg consensus estimats of 700,000 jobs added by 150,000, pointing to a faster-than-expected acceleration. Additionally, private payrolls beat expectations of 600,000 jobs added by 62,000, according to the figures released Friday by the Bureau of Labor Statistics.

SPY

1 minute read

Why A Northstar Analyst Is Bullish On This Disruptive MedTech Company

By Nikhil Dayal

Today, 3:24 AM

A strong value proposition and high retention rate have turned Northland Capital Markets bullish on Biotricity, Inc (OTC: BTCY). The Biotricity Analyst: Analyst Jason Wittes initiated coverage on Biotricity with an Outperform rating, setting a share price target of $7.

BTCY

2 minute read

This Discounted Stock Is Driving 21st Century Device Communication: Argus Research

By Nikhil Dayal

Today, 3:24 AM

A bet on the growing demand for radio frequency solutions spanning several markets and a value discount to competitors has made Argus Research bullish on Qorvo, Inc. (NASDAQ: QRVO).

QRVO

1 minute read

The Beauty Health Co.’s First-Mover Advantages Have Turned Goldman Sachs Analysts Bullish

By Nikhil Dayal

Today, 3:24 AM

First-mover advantages and projections of a rapidly growing medspa facial treatment market have made Goldman Sachs bullish on The Beauty Health Co. (NASDAQ: SKIN).

SKIN